AlleyWatch |
- Constrafor Raises $6.3M to Streamline Workflows in the Construction Industry and Improve Cash Flows for Subcontractors
- The AlleyWatch Startup Daily Funding Report: 6/3/2022
- Innerwell Raises $3M to Make Psychedelic-Assisted Psychotherapy Mainstream
- The AlleyWatch Startup Daily Funding Report: 6/2/2022
- The AlleyWatch May 2022 New York Venture Capital Funding Report
| Posted: 03 Jun 2022 10:27 AM PDT Effective cash flow management is essential to any construction project. With already so many moving parts in any project, the model of general contractors and subcontractors introduces complexities as an entire project can be beholden to any one part. Constrafor is an industry-specialized SaaS platform that allows general contracts and subcontractors to manage workflow and the procurement process in a centralized location. The platform also has finance options embedded for subcontractors to factor their invoices. By ensuring timely cash flows, Constrafor is attacking the cause of significant delays within the construction industry. Covering contracts, invoices and payments, AR processing, insurance requirements, and diversity procurement requirements, the company has built a network of 15,000+ contractors that have supported over 1500+ projects since the company's founding in the Fall of 2019. AlleyWatch caught up with Constrafor CEO and Founder Anwar Ghauche to learn more about the business, the company's strategic plans, latest round of funding, and much, much more... |
| The AlleyWatch Startup Daily Funding Report: 6/3/2022 Posted: 03 Jun 2022 09:27 AM PDT The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 6/3/2022 featuring funding details for Emissary, Plus Products, and much more. |
| Innerwell Raises $3M to Make Psychedelic-Assisted Psychotherapy Mainstream Posted: 03 Jun 2022 06:27 AM PDT There has been a resurgence in the debate about the clinical use of Psychedelic therapies or psychedelic-assisted psychotherapy (PAP). There's been increased legalization of substances and ketamine has been the most-studied psychedelic drug for its promising response to treating mental health conditions especially when it comes to healing patients from past trauma as well as anxiety and depression. Innerwell is a newly-launched telehealth platform that provides ketamine-assisted psychotherapy. The company focuses on a coordinated care model to unlock a new care pathway for patients for whom traditional pharmacological routes have not worked. The company takes a holistic approach by offering peer-to-peer support, guided meditations, and other resources in addition to therapy sessions and access to medicine. Initially focusing on virtual care, Innerwell does plan to expand to offer in-person care as well as add other psychedelics to its offering like MDMA when they are FDA-approved. AlleyWatch caught up with Innerwell Founder and CEO Lisa Kennedy to learn more about the business, the company's strategic plans, recent round of funding, and much, much more... |
| The AlleyWatch Startup Daily Funding Report: 6/2/2022 Posted: 02 Jun 2022 08:27 AM PDT The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 6/2/2022 featuring funding details for Massive Bio, Kickoff, and much more. |
| The AlleyWatch May 2022 New York Venture Capital Funding Report Posted: 02 Jun 2022 06:27 AM PDT Despite global macroeconomic uncertainty, $1.6B in new funding for NYC startups across 92 deals; 5 mega ($100M+) deals! Find out where the money went across all rounds in NYC Tech in May. |
| You are subscribed to email updates from AlleyWatch. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment